On January 3, 2022 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and company presentations at the following investor conferences (Press release, Herantis Pharma, JAN 3, 2022, View Source,c3480839 [SID1234597949]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright BioConnect Conference, US – January 10th – 13th, 2022 (Virtual)

The presentation will be held on January 10th at 14:00 – 14:30 EET / 13:00 – 13:30 CET. 1×1 meetings will be scheduled during January 10-13th.

Biotech Showcase, US – January 10-12 and 17-19, 2022 (Virtual)

The presentation will be held on January 11th at 02:00 EET – 02:30 EET / 01:00 CET – 1:30 CET. 1×1 meetings will be scheduled during January 17-19th.

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the conference organizers, or send an email to [email protected], if you wish to schedule a meeting with Herantis.